Table of Contents
Chapter 1 Report Scope
1.1 Market Segmentation And Scope
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
Chapter 2 Research Methodology
2.1 Research Methodology
2.1.1 Information Procurement
2.2 Information Or Data Analysis
2.3 Market Formulation & Validation
2.4 Region-Wise Market Calculation
2.4.1 Region-Wise Market: Base Estimates
2.4.2 Global Market: CAGR Calculation
2.5 Region-Based Segment Share Calculation
2.6 Model Details
2.6.1 Commodity Flow Analysis (Model 1)
2.6.2 Volume Price Analysis (Model 2)
2.7 List Of Secondary Sources
Chapter 3 Objectives
3.1 Objective – 1
3.2 Objective – 2
3.3 Objective – 3
3.4 Objective – 4
Chapter 4 Executive Summary
4.1 Market Outlook
4.2 Segment Outlook
4.3 Competitive Insights
4.4 Market Snapshot
Chapter 5 Industry Outlook
5.1 Penetration & Growth Prospect Mapping
5.2 Regulatory Framework
5.3 Market Dynamics
5.3.1 Market Driver Analysis
5.3.1.1 Growing Prevalence Of Breast Cancer
5.3.1.2 Technological Advancements In The Field Of Breast Imaging
5.3.1.3 Investments And Initiatives From Various Organizations In Breast Cancer Screening Campaigns
5.3.2 Market Restraint Analysis
5.3.2.1 Risk Of Adverse Effects From Radiation Exposure
5.3.2.2 High Cost Of Imaging Systems
5.4 Breast Imaging Market Analysis Tools
5.4.1 SWOT Analysis, By PEST
5.4.2 Porter’s Five Forces Analysis
5.5 Impact Of COVID-19
5.5.1 Supply Chain
5.5.2 Changing Market Trends
Chapter 6 Breast Imaging Market: Segment Analysis, By Technology, 2018 – 2030 (USD Million)
6.1 Definitions & Scope
6.2 Technology Market Share Analysis, 2022 & 2030
6.3 Breast Imaging Market, By Technology, 2018 To 2030
6.4 Market Size Forecasts And Trend Analysis
6.4.1 Ionizing
6.4.1.1 Ionizing Market, 2018 – 2030 (USD Million)
6.4.1.1.1 Full-Field Digital Mammography
6.4.1.1.2 Analog Mammography
6.4.1.1.3 Positron Emission Mammography
6.4.1.1.4 Electric Impedance Tomography
6.4.1.1.5 Cone-Beam Computed Tomography
6.4.1.1.6 Positron Emission Tomography & Computed Tomography
6.4.1.1.7 Positron Emission Tomography & Computed Tomography
6.4.1.1.8 3D Breast Tomosynthesis
6.4.1.1.9 MBI/BSGI
6.4.2 Non-Ionizing
6.4.2.1 Non-Ionizing Market, 2018 – 2030 (USD Million)
6.4.1.1.1 MRI
6.4.1.1.2 Thermography
6.4.1.1.3 Ultrasound
6.4.1.1.4 Electric Impedance Tomography
6.4.1.1.5 Optical Imaging
6.4.1.1.6 Automated Whole-Breast Ultrasound
Chapter 7 Breast Imaging Market: Segment Analysis, By End-Use, 2018 – 2030 (USD Million)
7.1 Definitions & Scope
7.2 End-Use Market Share Analysis, 2022 & 2030
7.3 Global Breast Imaging Market, By End-Use, 2018 To 2030
7.4 Market Size Forecasts & Trend Analysis
7.4.1 Hospitals
7.4.1.1 Hospitals Market, 2018 – 2030 (USD Million)
7.4.2 Breast Care Centers
7.4.2.1 Breast Care Centers Market, 2018 – 2030 (USD Million)
7.4.3 Diagnosis Imaging Centers
7.4.3.1 Diagnosis Imaging Centers Market, 2018 – 2030 (USD Million)
Chapter 8 Breast Imaging Market: Regional Market Analysis, By Technology, 2018 – 2030 (USD Million)
8.1 Definitions & Scope
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 Regional Market Snapshot
8.4 Market Size Forecasts & Trend Analysis
8.4.1 North America
8.4.1.1 North America Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.1.2 U.S.
8.4.1.2.1 U.S. Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.1.3 Canada
8.4.1.3.1 Canada Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.2 Europe
8.4.2.1 Europe Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.2.2 U.K.
8.4.2.2.1 U.K. Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.2.3 Germany
8.4.2.3.1 Germany Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.2.4 France
8.4.2.4.1 France Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.2.5 Italy
8.4.2.5.1 Italy Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.2.6 Spain
8.4.2.6.1 Spain Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.2.7 Sweden
8.4.2.7.1 Sweden Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.2.8 Norway
8.4.2.8.1 Norway Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.2.9 Denmark
8.4.2.9.1 Denmark Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.3 Asia Pacific
8.4.3.1 Asia Pacific Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.3.2 Japan
8.4.3.2.1 Japan Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.3.3 China
8.4.3.3.1 China Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.3.4 India
8.4.3.4.1 India Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.3.5 Australia
8.4.3.5.1 Australia Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.3.6 South Korea
8.4.3.6.1 South Korea Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.3.7 Thailand
8.4.3.7.1 Thailand Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.4 Latin America
8.4.4.1 Latin America Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.4.2 Brazil
8.4.4.2.1 Brazil Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.4.3 Mexico
8.4.4.3.1 Mexico Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.4.4 Argentina
8.4.4.4.1 Argentina Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.5 Middle East & Africa
8.4.5.1 Middle East & Africa Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.5.2 South Africa
8.4.5.2.1 South Africa Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.5.3 Saudi Arabia
8.4.5.3.1 Saudi Arabia Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.5.4 UAE
8.4.5.4.1 UAE Breast Imaging Market, 2018 – 2030 (USD Million)
8.4.5.5 Kuwait
8.4.5.5.1 Kuwait Breast Imaging Market, 2018 – 2030 (USD Million)
Chapter 9 Breast Imaging Market: Competitive Analysis
9.1 Company Profiles
9.1.1 GE Healthcare
9.1.1.1 Company Overview
9.1.1.2 Financial Performance
9.1.1.3 Product Benchmarking
9.1.1.4 Strategic Initiatives
9.1.2 Hologic, Inc.,
9.1.2.1 Company Overview
9.1.2.2 Financial Performance
9.1.2.3 Product Benchmarking
9.1.2.4 Strategic Initiatives
9.1.3 Philips Healthcare
9.1.3.1 Company Overview
9.1.3.2 Financial Performance
9.1.3.3 Product Benchmarking
9.1.3.4 Strategic Initiatives
9.1.4 Gamma Medica, Inc.
9.1.4.1 Company Overview
9.1.4.2 Financial Performance
9.1.4.3 Product Benchmarking
9.1.4.4 Strategic Initiatives
9.1.5 Siemens Healthcare
9.1.5.1 Company Overview
9.1.5.2 Financial Performance
9.1.5.3 Product Benchmarking
9.1.5.4 Strategic Initiatives
9.1.6 Fujifilm Holdings Corp.
9.1.6.1 Company Overview
9.1.6.2 Financial Performance
9.1.6.3 Product Benchmarking
9.1.6.4 Strategic Initiatives
9.1.7 Sonocine, Inc.
9.1.7.1 Company Overview
9.1.7.2 Financial Performance
9.1.7.3 Product Benchmarking
9.1.7.4 Strategic Initiatives
9.1.8 Toshiba Corporation
9.1.8.1 Company Overview
9.1.8.2 Financial Performance
9.1.8.3 Product Benchmarking
9.1.8.4 Strategic Initiatives
9.1.9 Dilon Technologies, Inc.
9.1.9.1 Company Overview
9.1.9.2 Financial Performance
9.1.9.3 Product Benchmarking
9.1.9.4 Strategic Initiatives
9.1.10 Aurora Imaging Technology, Inc.
9.1.10.1 Company Overview
9.1.10.2 Financial Performance
9.1.10.3 Product Benchmarking
9.1.10.4 Strategic Initiatives
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer